Investors
Investors
Hello. We are Haleon. We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity.
Haleon is an impressive business, with a clear strategy to drive sustainable above-market growth and attractive shareholder returns.
With a strong purpose of delivering better everyday health with humanity at our core, I’m confident Haleon is primed and ready for the next stage of its remarkable journey.
By the numbers
We are one of the world's largest providers of specialist oral health. With a broad range of science-based products our goal is to make the world's mouths healthier.
We have a category leading portfolio of brands to improve everyday health and wellness.
With a portfolio of products to relieve pain and reduce inflammation, our range brings comfort and ease to millions.
Our portfolio of leading brands in cold and flu, nasal decongestant and allergy helps people worldwide with a range of respiratory issues.
We have a portfolio of trusted, market leading digestive health brands, including Eno and Tums, with a strong heritage in treating heartburn, acid indigestion and gastric discomfort.
2022 Revenue
2022 Revenue
2022 Revenue
2022 Revenue
2022 Revenue
Trading through the year has been strong with reported revenue growth of 13.8% and organic revenue growth of 9.0%, with good growth across all regions and categories demonstrating the long-term attractiveness of our brands and the categories in which we operate. Our growth was balanced with price of 4.3% and volume/mix 4.7%.
By the numbers
(2021: £9.5bn)
(2021: (3.5)%)
(2021: 3.8%)
(2021: £1.6bn)
(2021: £2.2bn)
(2021: 17.2%)
(2021: 22.8%)
(2021: 15.1p)
(2021: 17.9p)
(2021: £1.4bn)
(2021: £1.2bn)
1Non-IFRS measures. We use certain non-IFRS alternative performance measures to provide additional information about the Company’s performance. Non-IFRS measures may be considered in addition to, but not as a substitute for or superior to, information presented in accordance with IFRS. For more information, see page 46 of the Annual Report and Form 20-F 2022.
A sustainable model driving investment for growth delivering attractive returns.
Haleon’s competitive advantage is derived from combining deep human understanding with trusted science.
Our KPIs track and measure our performance, delivery against our strategic pillars and long-term success.
This measures the strength of our existing portfolio, operations and resources.
Reducing our leverage strengthens our balance sheet and maintains our investment grade credit rating.
Our adjusted operating profit is an important indicator of the strength of our business model.
Free cash flow provides the business with capacity to invest in the business, pay down debt and shareholder returns.
This is based on the Group’s analysis of third-party market data of revenue, including IQVIA, IRI and Nielsen data.
Carbon reduction5
Recycle-ready packaging6
Gender diversity
Employee engagement
5Reporting period runs from 1 December 2021 to 30 November 2022. Carbon offsets account for 15% of our market based Scope 1 and 2 carbon emissions.
6Reporting period runs from 1 July 2021 to 30 June 2022.
From the report
Request a printed Annual Report and Form 20-F 2022.
Related
